Abstract
A novel circulation phosphaturic hormone is postulated to regulate systemic phosphate homeostasis. Two new studies reveal that the phosphaturic factor FGF-23 is increased in hypophosphatemic subjects with McCune-Albright syndrome and that secreted frizzled-related protein-4 (sFRP-4), a factor produced by tumors derived from subjects with tumor-induced osteomalacia, also has phosphaturic activity. It remains to be established whether FGF-23 and sFRP-4 represent two distinct phosphatonins or are somehow integrated in a novel phosphate-regulating bone-kidney axis.
Publication types
-
Research Support, U.S. Gov't, P.H.S.
-
Comment
MeSH terms
-
Animals
-
Bone and Bones / metabolism*
-
Calcification, Physiologic
-
Extracellular Matrix Proteins*
-
Fibroblast Growth Factor-23
-
Fibroblast Growth Factors / physiology
-
Glycoproteins / physiology
-
Homeostasis*
-
Humans
-
Kidney / metabolism*
-
Mice
-
Phosphates / metabolism*
-
Phosphoproteins / physiology
-
Proto-Oncogene Proteins / physiology
Substances
-
Extracellular Matrix Proteins
-
Glycoproteins
-
MEPE protein, human
-
Phosphates
-
Phosphoproteins
-
Proto-Oncogene Proteins
-
SFRP4 protein, human
-
Sfrp4 protein, mouse
-
Fibroblast Growth Factors
-
Fibroblast Growth Factor-23